Science Explorer Interactive view Map
Company · Lund · Sweden

Red Glead Discovery (Sweden)

redglead.comROR OpenAlex
Research works
8
▲ 920% vs 2013–17
Citations
146
17.9 per fractional work
Top-10% rate
20.7%
record average 16.5%
Open access
64%
world 28%

Not ranked overall: Red Glead Discovery (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.05× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 12.13× its world share, 1 worksImmunology and Micro…Neuroscience: 0.88× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 22.26× its world share, 0 worksPharmacology, Toxico…Chemistry: 5.72× its world share, 0 worksChemistryComputer Science: 0.31× its world share, 0 worksComputer ScienceEnvironmental Science: 1.55× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.91× its world share, 0 worksHealth ProfessionsMedicine: 1.45× its world share, 1 worksMedicineVeterinary: 3.77× its world share, 0 worksVeterinaryPsychology: 0.59× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 22.3×. Every wedge is a field page.

Which research topics does Red Glead Discovery (Sweden) publish most on?

By volume in 2022–2025: Galectins and Cancer Biology, Chemical Synthesis and Analysis, Autophagy in Disease and Therapy and RNA and protein synthesis mechanisms.

Galectins and Cancer Bio…0Galectins and Cancer Biology: 0 fractional worksChemical Synthesis and A…0Chemical Synthesis and Analysis: 0 fractional worksAutophagy in Disease and Therapy: 0 fractional worksRNA and protein synthesis mechanisms: 0 fractional worksChemical Reactions and I…0Chemical Reactions and Isotopes: 0 fractional worksToxin Mechanisms and Immunotoxins: 0 fractional worksChemistry and Chemical Engineering: 0 fractional worksPARP inhibition in cance…0PARP inhibition in cancer therapy: 0 fractional worksChemical Synthesis and Reactions: 0 fractional worksBacteriophages and microbial interactions: 0 fractional works
ImmunologyMolecular BiologyEpidemiologyPharmaceutical Science4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Galectins and Cancer Biology Immunology 0 works
  2. 2 Chemical Synthesis and Analysis Molecular Biology 0 works
  3. 3 Autophagy in Disease and Therapy Epidemiology 0 works
  4. 4 RNA and protein synthesis mechanisms Molecular Biology 0 works
  5. 5 Chemical Reactions and Isotopes Pharmaceutical Science 0 works
  6. 6 Toxin Mechanisms and Immunotoxins Immunology 0 works
  7. 7 Chemistry and Chemical Engineering Environmental Chemistry 0 works
  8. 8 PARP inhibition in cancer therapy Oncology 0 works
  9. 9 Chemical Synthesis and Reactions Organic Chemistry 0 works
  10. 10 Bacteriophages and microbial interactions Ecology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available63.8%not open36.2%

World: 28% of research is openly available.

with international co-authors57.3%domestic only42.7%

World: 19% is written across borders.

How has Red Glead Discovery (Sweden)'s research output changed?

Output in 2018–2022 was 920% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Lund

All research institutions in Lund

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.